Search
TOPIC IN FOCUS
The latest news and developments that advisors need to create meaningful tax planning strategies for clients.
MORE TO EXPLORE
Expert Perspectives is the home to the voices of industry leaders, as they share their expertise and insights directly from the field.
Discover relevant content from across the suite of ALM legal publications
Media & Resources
Drugmaker Vivus Inc. said Monday that regulators will take another three months to make a decision on its closely-watched obesity drug Qnexa, which could become the first new prescription drug to reach the market in more than a decade.